Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Del Rosso

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Arthritis and Rheumatism|May 28, 2010
Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12Francesca Margheri, Simona Serratì, Andrea Lapucci, et al.
Biochemical Pharmacology|December 2, 2008
TGFbeta1 antagonistic peptides inhibit TGFbeta1-dependent angiogenesisSimona Serratì, Francesca Margheri, Marco Pucci, et al.
Rheumatology (Oxford, England)|January 27, 2022
Erratum to: Parvovirus B19 induces cellular senescence in human dermal fibroblasts: putative role in systemic sclerosis-associated fibrosisRosaria Arvia, Krystyna Zakrzewska, Lisa Giovannelli, et al.
Rheumatology (Oxford, England)|December 10, 2021
Parvovirus B19 induces cellular senescence in human dermal fibroblasts: putative role in systemic sclerosis-associated fibrosisRosaria Arvia, Krystyna Zakrzewska, Lisa Giovannelli, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|August 20, 2016
Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synoviumFrancesca Margheri, Mariangela Ceruso, Fabrizio Carta, et al.
Ebiomedicine|January 7, 2019
EGFR/uPAR interaction as druggable target to overcome vemurafenib acquired resistance in melanoma cellsAnna Laurenzana, Francesca Margheri, Alessio Biagioni, et al.
International Journal of Cancer|April 1, 2004
Antisense oligodeoxynucleotides for urokinase-plasminogen activator receptor have anti-invasive and anti-proliferative effects in vitro and inhibit spontaneous metastases of human melanoma in miceSilvia D'Alessio, Francesca Margheri, Marco Pucci, et al.
International Journal of Oncology|June 9, 2005
The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat proteinFrancesca Margheri, Silvia D'Alessio, Simona Serratì, et al.
Arthritis and Rheumatism|November 30, 2006
Domain 1 of the urokinase-type plasminogen activator receptor is required for its morphologic and functional, beta2 integrin-mediated connection with actin cytoskeleton in human microvascular endothelial cells: failure of association in systemic sclerosis endothelial cellsFrancesca Margheri, Mirko Manetti, Simona Serratì, et al.
International Journal of Cancer|June 4, 2017
uPA/uPAR system activation drives a glycolytic phenotype in melanoma cellsAnna Laurenzana, Anastasia Chillà, Cristina Luciani, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Arthritis and Rheumatism|May 28, 2010
Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12Francesca Margheri, Simona Serratì, Andrea Lapucci, et al.
Biochemical Pharmacology|December 2, 2008
TGFbeta1 antagonistic peptides inhibit TGFbeta1-dependent angiogenesisSimona Serratì, Francesca Margheri, Marco Pucci, et al.
Rheumatology (Oxford, England)|January 27, 2022
Erratum to: Parvovirus B19 induces cellular senescence in human dermal fibroblasts: putative role in systemic sclerosis-associated fibrosisRosaria Arvia, Krystyna Zakrzewska, Lisa Giovannelli, et al.
Rheumatology (Oxford, England)|December 10, 2021
Parvovirus B19 induces cellular senescence in human dermal fibroblasts: putative role in systemic sclerosis-associated fibrosisRosaria Arvia, Krystyna Zakrzewska, Lisa Giovannelli, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|August 20, 2016
Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synoviumFrancesca Margheri, Mariangela Ceruso, Fabrizio Carta, et al.
Ebiomedicine|January 7, 2019
EGFR/uPAR interaction as druggable target to overcome vemurafenib acquired resistance in melanoma cellsAnna Laurenzana, Francesca Margheri, Alessio Biagioni, et al.
International Journal of Cancer|April 1, 2004
Antisense oligodeoxynucleotides for urokinase-plasminogen activator receptor have anti-invasive and anti-proliferative effects in vitro and inhibit spontaneous metastases of human melanoma in miceSilvia D'Alessio, Francesca Margheri, Marco Pucci, et al.
International Journal of Oncology|June 9, 2005
The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat proteinFrancesca Margheri, Silvia D'Alessio, Simona Serratì, et al.
Arthritis and Rheumatism|November 30, 2006
Domain 1 of the urokinase-type plasminogen activator receptor is required for its morphologic and functional, beta2 integrin-mediated connection with actin cytoskeleton in human microvascular endothelial cells: failure of association in systemic sclerosis endothelial cellsFrancesca Margheri, Mirko Manetti, Simona Serratì, et al.
International Journal of Cancer|June 4, 2017
uPA/uPAR system activation drives a glycolytic phenotype in melanoma cellsAnna Laurenzana, Anastasia Chillà, Cristina Luciani, et al.
Pageof 8